Eugene

[email protected]

LATEST

Selexis in Biologics Supply Pact
By

By
Selexis SA, a Geneva, Switzerland-based provider of mammalian cell-line generation technology, has agreed to license its mammalian cell line-based protein expression platform (SUREtechnology) to Compugen, a Richmond Hill, Ontario, Canada-headquartered…

AGC Biologics To Expand Biologics Capacity
By

By
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization, is adding a 2,000-liter single-use bioreactor (SUB) to its Berkeley, California facility. AGC’s Berkeley facility offers cell-culture manufacturing in scales…

Pfizer, AstraZeneca Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Pfizer and AstraZeneca. Editor’s Note: This article was updated on a continuous basis…

Sanofi, Evotec To Create Infectious Disease R&D Platform
By

By
Sanofi and Evotec AG, a Hamburg, Germany-based drug discovery and development company, have agreed to support Evotec in opening a new innovation platform near Lyon, France for infectious disease research…

Pfizer’s Hospira Voluntarily Recalls Three Lots of Opioid Drug Over Possible Cracked Vials
By

By
Hospira, a Pfizer company, is voluntarily recalling three lots of hydromorphone HCI injection, an opioid agonist for pain relief, to the hospital/institution level. Hospira initiated the recall on February 07,…

Sanofi Completes $11.6-Billion Acquisition of Biogen Spin-off Bioverativ
By

By
Sanofi has completed its previously announced $11.6-billion acquisition of Bioverativ, a Waltham, Massachusetts-headquartered company created from the spin-off of Biogen’s hemophilia business. The deal was announced in January 2018. Biogen…

Eisai, Merck & Co. in Cancer Pact Worth up to $5.76 Billion
By

By
Eisai and Merck & Co. have partnered for worldwide co-development and co-commercialization of Lenvima (lenvatinib mesylate), a drug for treating thyroid cancer discovered by Eisai, in a deal worth up…

Cigna To Acquire Express Scripts in $67-Billion Deal
By

By
In a move reflecting increased consolidation in the healthcare value chain, Cigna Corporation, a Bloomfield, Connecticut-headquartered health insurance company, has agreed to acquire Express Scripts Holding, a St. Louis, Missouri-headquartered…

Pharma Industry Responds to Latest Brexit Plan
By

By
As negotiations between the European Union (EU) and the UK continue on a possible trade agreement in relation to the UK’s exit from the EU (i.e., Brexit) the pharmaceutical industry…

Grand River Aseptic Manufacturing Expands Syringe-Filling Capabilities
By

By
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, is expanding its capabilities in syringe filling at its manufacturing facility in Grand Rapids. GRAM is installing…